|
|
 |
|
Viewing report
|
|
|
|
AIDS and Tuberculosis: A Deadly Liaison
John Wiley and Sons Ltd, Oct 2009, Pages: 320
The immune deficiency AIDS leads to a drastic increase in susceptibility to Tuberculosis. Accordingly, co-infections of tuberculosis (TB) and AIDS have increased dramatically over the last decades and have already killed more than 5 million people worldwide. Currently, no vaccines are available for either of these diseases leaving doctors with limited options for prevention. This perfect storm of pandemics is analysed and explained for the first time in this groundbreaking title, edited by two of the most accomplished experts in this area, Prof. Dr. Dr. h.c. Stefan Kaufmann at the Max-Planck Institute for infectious diseases in Berlin and Prof. Dr. Bruce Walker, director of the Ragon Institute of MGH, MIT and Harvard in Boston.
Co-infection of AIDS and TB occur frequently in the most impoverished regions of the world and the AIDS pandemic which has spread rapidly across Africa over the past two decades is now being met by a TB pandemic.
While TB can be cured and AIDS can be treated, co-infection in a single patient presents unique challenges and the rapid expansion of these two pandemics has resulted in a critical need to better understand the interactions between the two pathogens and to integrate research efforts.
This title brings together scientists from the forefront of research to explore and combine state-of-the-art studies in drug interactions and disease therapies, providing the latest information about prevention, therapy and diagnosis of both tuberculosis and AIDS.
This is the only book to place a clear emphasis on the increasing number of patients suffering from both tuberculosis and AIDS and is unique in combining expertise from both fields. Using a multi-disciplinary approach the authors bring together the issues surrounding treatment of co-infection by highlighting the problems of treatment overlap and providing new data demonstrating exactly how this deadly liaison plays out.
Early chapters focus on immunology and the problems facing vaccination strategies for both diseases. Currently no vaccines exist for either disease and the coexistence of both pathogens in a single patient complicates the research for new preventive, diagnostic or therapeutic approaches.
Later chapters deal with some of the most threatening consequences of this co-infection, such as the emergence of drug resistant TB. These chapters also deal with the need to simultaneously treat both infections, highlighting the major problem of drug interaction if two treatments which have been researched in isolation are given to one individual.
Together the contributing authors offer a refreshingly new and engaging analysis of this most challenging of topics and offer new therapeutic approaches by providing comprehensive understanding of both diseases.
This title is of strong interest to a broad range of research communities, from microbiologists and virologists to immunologists and medical doctors specializing in TB and AIDS treatment as well as to the pharmaceutical and biotechnological Industries.
Aids and Tuberculosis: A Deadly Liaison is the first title in Wiley-Blackwell's new 'Infection Biology Series'. The second title in the series will be Bacterial Virulence: Basic Principles, Models and Global Approaches, edited by Philippe Sansonetti from the Pasteur Institute in Paris. It is due for publication in spring 2010.
Customers who bought this item also bought
Competitor Analysis: Tuberculosis Vaccines and Therapeutics
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
Outpatient Management of HIV Infection, Fourth Edition
Advances in Vaccine Technology and Delivery
Molecular Diagnostics - Technologies, Markets and Companies
HIV/AIDS Testing - Global Strategic Business Report
Emerging Blood Typing, Grouping and Infectious Disease Screening Tests and Companies Developing New Technologies
Blood Typing, Grouping and Infectious Disease Screening Tests: Emerging Assays and Companies Developing New Technologies and Products
Tuberculosis Therapeutics - Global Strategic Business Report
|
|
|
|
